Filing Details
- Accession Number:
- 0001144204-17-002837
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-19 10:56:58
- Reporting Period:
- 2017-01-17
- Filing Date:
- 2017-01-19
- Accepted Time:
- 2017-01-19 10:56:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385508 | Opiant Pharmaceuticals Inc. | OPNT | Metal Mining (1000) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1656633 | Roger Crystal | C/O Opiant Pharmaceuticals, Inc. 401 Wilshire Blvd., 12Th Floor Santa Monica CA 90401 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-01-17 | 3,475 | $6.99 | 8,475 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.955 to $7.00, inclusive.